Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. Cellectis S.A.
  6. News
  7. Summary
    ALCLS   FR0010425595

CELLECTIS S.A.

(ALCLS)
  Report
Real-time Quote. Real-time Euronext Paris - 12/03 10:37:42 am
7.255 EUR   -3.01%
12/02European ADRs Move Higher in Thursday Trading
MT
12/01European ADRs Move Sharply Higher in Wednesday Trading
MT
11/30European ADRs Move Lower in Tuesday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about CELLECTIS S.A.
12/01European ADRs Move Sharply Higher in Wednesday Trading
MT
11/30JMP Securities Starts Cellectis at Market Outperform With $20 Price Target
MT
11/24Cellectis S.A. Announces Executive Changes
CI
11/24Cellectis S.A. Announces Resignation of Eric Dutang as Chief Financial Officer, Effecti..
CI
11/19Cellectis, Cytovia Therapeutics Expand Gene-Edited Cells Partnership In China
MT
11/18CELLECTIS S A : Cytovia and Cellectis Expand Their TALEN« Gene-Edited iNK Partnership to E..
PU
11/18Cytovia and Cellectis Expand Their TALEN« Gene-Edited iNK Partnershipáto Enable Broader..
AQ
11/18Cytovia and Cellectis Expand TALEN Gene-Edited iNK Partnership?to Enable Broader Collab..
CI
11/12Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Produc..
PU
11/12Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Produc..
GL
11/12Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Produc..
GL
11/12Cellectis Presents First Preclinical Data on UCARTMESO
CI
11/04Cellectis Provides Business Update and Reports Financial Results for Third Quarter and ..
PU
11/04PRELIMINARY NOTE - Form 6-K
PU
11/04Third Quarter 2021 Financial Results
PU
More most relevant news
All news about CELLECTIS S.A.
12/02European ADRs Move Higher in Thursday Trading
MT
12/01European ADRs Move Sharply Higher in Wednesday Trading
MT
11/30European ADRs Move Lower in Tuesday Trading
MT
11/30JMP Securities Starts Cellectis at Market Outperform With $20 Price Target
MT
11/24Cellectis S.A. Announces Executive Changes
CI
11/24Cellectis S.A. Announces Resignation of Eric Dutang as Chief Financial Officer, Effecti..
CI
11/24European ADRs Move Lower in Wednesday Trading
MT
11/19Cellectis, Cytovia Therapeutics Expand Gene-Edited Cells Partnership In China
MT
11/18CELLECTIS S A : Cytovia and Cellectis Expand Their TALEN« Gene-Edited iNK Partnership to E..
PU
11/18Cytovia and Cellectis Expand Their TALEN« Gene-Edited iNK Partnershipáto Enable Broader..
AQ
More news
News in other languages on CELLECTIS S.A.
12/02Les ADR européens sont en hausse jeudi
12/01Les ADR européens sont en forte hausse ce mercredi
11/30Les ADR européens en baisse mardi
11/24Les ADR européens en baisse mercredi
11/19Cellectis et Cytovia Therapeutics étendent leur partenariat sur les cellules génétiquem..
11/12SOCIETY FOR IMMUNOTHERAPY OF CANCER : Cellectis présente les premières données précliniqu..
11/05EN DIRECT DES MARCHES : Axa, Orange, Euronext, Casino, Airbus, JCDecaux, Spie...
11/05Stop ou encore ?
11/04Comptes consolidés comptes intermédiaires au 30 septembre 2021
11/04Cellectis publie ses résultats financiers pour le troisième trimestre et pour les neuf ..
More news
Analyst Recommendations on CELLECTIS S.A.
11/30JMP Securities Starts Cellectis at Market Outperform With $20 Price Target
MT
10/08CELLECTIS S A : Baird Downgrades Cellectis to Neutral from Outperform, Adjusts Price Targe..
MT
04/28CELLECTIS S A : Guggenheim Downgrades Cellectis to Neutral from Buy
MT
03/16CELLECTIS S A : Baird Upgrades Cellectis to Outperform From Neutral, Adjusts Price Target ..
MT
More recommendations
Press releases
11/18CELLECTIS S A : Cytovia and Cellectis Expand Their TALEN« Gene-Edited iNK Partnership to E..
PU
11/18Cytovia and Cellectis Expand Their TALEN« Gene-Edited iNK Partnershipáto Enable Broader..
AQ
11/12Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Produc..
PU
11/12Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Produc..
GL
11/12Cellectis Presents First Preclinical Data on UCARTMESO, an Allogeneic CAR-T Cell Produc..
GL
More press releases
Upcoming event on CELLECTIS S.A.
12/11/21